Results 101 to 110 of about 114,817 (184)

Efficacy and safety of pharmacological interventions for the treatment of cocaine use disorder: A systematic review and network meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson, Thomas Parkhouse, Chloe Burke, Monika Halicka, Jennifer C. Palmer, Hend Gabr, Rebecca Wilson, Katie E. Webster, Francesca Spiga, Sarah Dawson, Deborah M. Caldwell, Jennifer Scott, Julian P. T. Higgins, Jelena Savović   +13 more
wiley   +1 more source

Editorial: Neuroendocrine research in health and disease, volume II

Frontiers in Neuroscience, 2023
Yu-Feng Wang, Keith Maurice Kendrick, Xue Qun Chen, Lei Sha   +3 more
doaj   +1 more source

From neuropeptides to toxins: illuminating the origins of venom complexity in cone snails. [PDF]

Mol Biol Evol
Koch TL, Ferrari G, Sumanam SB, Salcedo PF, Watkins M, Chase K, Tooming-Klunderud A, Lluisma AO, Yanagihara A, Young ND, Olivera BM, Undheim EAB, Safavi-Hemami H.   +12 more
europepmc   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Marine flatworms as windows into the evolution of bilaterian neuropeptide signalling. [PDF]

J Neuroendocrinol
Nakamura R, Hamada M, Bailly X, Sakamoto H, Sakamoto T.   +4 more
europepmc   +1 more source

Editorial: Neuropeptide actions in arthropod biology

Frontiers in Endocrinology
Qisheng Song, David Stanley
doaj   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Editorial: The Role of Neuropeptides in Sleep/Wakefulness States and the Circadian Clock

Frontiers in Neuroscience, 2022
Natsuko Tsujino, Masayuki Ikeda, Arisa Hirano, Takeshi Sakurai   +3 more
doaj   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Neuropeptide visualization using split GFP in live C. elegans. [PDF]

PLoS One
Aleogho BM, Yokosawa R, Noma K.
europepmc   +1 more source